These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 26582036)

  • 1. The drug-drug interaction of sorafenib mediated by P-glycoprotein and CYP3A4.
    Wang X; Zhang X; Huang X; Li Y; Wu M; Liu J
    Xenobiotica; 2016 Jul; 46(7):651-658. PubMed ID: 26582036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of verapamil on pharmacokinetics of pristimerin in rats.
    Gao X; Zhang Y; Wang Y; Zhang Y; Wang Y; Liu S; Gao X
    Biomed Chromatogr; 2016 Jun; 30(6):802-9. PubMed ID: 26347996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Verapamil, a P-glycoprotein-1 and Cytochrome P450 3A4 Inhibitor, on Pharmacokinetics and Metabolic Stability of Ripretinib: A Drug-Drug Interaction Study in Rats.
    Mudavath S; Ashok D
    Eur J Drug Metab Pharmacokinet; 2023 Nov; 48(6):733-746. PubMed ID: 37831396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of verapamil on the pharmacokinetics of dihydromyricetin in rats and its potential mechanism.
    Huang Y; Zhao J; Jian W; Wang G
    Xenobiotica; 2018 Aug; 48(8):839-844. PubMed ID: 28795912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Verapamil on Pharmacokinetics of Triptolide in Rats.
    Zhang Y; Li J; Lei X; Zhang T; Liu G; Yang M; Liu M
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):449-56. PubMed ID: 25854676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of verapamil on the pharmacokinetics of curculigoside in rats.
    Wang K; Zhao J; Lang J
    Pharm Biol; 2016 Dec; 54(12):3001-3008. PubMed ID: 27328778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of triptolide on the pharmacokinetics of sorafenib in rats and its potential mechanism.
    Wang X; Zhang X; Liu F; Wang M; Qin S
    Pharm Biol; 2017 Dec; 55(1):1863-1867. PubMed ID: 28614959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption and Metabolism Characteristics of Triptolide as Determined by a Sensitive and Reliable LC-MS/MS Method.
    Gong X; Chen Y; Wu Y
    Molecules; 2015 May; 20(5):8928-40. PubMed ID: 25993421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption and metabolism characteristics of pristimerin as determined by a sensitive and reliable LC-MS/MS method.
    Dong C; Xu C; Liu H; Xu S; Gao Y; Peng J
    Fitoterapia; 2015 Oct; 106():62-7. PubMed ID: 26299424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-glycoprotein and cytochrome P450 3A4 involvement in risperidone transport using an in vitro Caco-2/TC7 model and an in vivo model.
    Cousein E; Barthélémy C; Poullain S; Simon N; Lestavel S; Williame V; Joiris E; Danel C; Clavey V; Brossard D; Robert H; Crauste-Manciet S; Vaccher C; Odou P
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):878-86. PubMed ID: 17337319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies.
    Yang C; Zhang T; Li Z; Xu L; Liu F; Ruan J; Liu K; Zhang Z
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):561-8. PubMed ID: 24120885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of quercetin on the pharmacokinetics of losartan and its metabolite EXP3174 in rats.
    Zhao Q; Wei J; Zhang H
    Xenobiotica; 2019 May; 49(5):563-568. PubMed ID: 29768080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro to in vivo evidence of the inhibitor characteristics of Schisandra lignans toward P-glycoprotein.
    Liang Y; Zhou Y; Zhang J; Liu Y; Guan T; Wang Y; Xing L; Rao T; Zhou L; Hao K; Xie L; Wang GJ
    Phytomedicine; 2013 Aug; 20(11):1030-8. PubMed ID: 23731657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of verapamil on the pharmacokinetics of puerarin in rats.
    Zhou Y; Song X; Dong G
    Xenobiotica; 2019 Oct; 49(10):1178-1182. PubMed ID: 30173622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport and uptake of clausenamide enantiomers in CYP3A4-transfected Caco-2 cells: An insight into the efflux-metabolism alliance.
    Hua F; Shi MJ; Zhu XL; Li M; Wang HX; Yu XM; Li Y; Zhu CJ
    Biochem Pharmacol; 2015 Nov; 98(1):224-30. PubMed ID: 26301745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic interaction of cytochrome P450 3A-related compounds with rhodamine 123, a P-glycoprotein substrate, in rats pretreated with dexamethasone.
    Yumoto R; Murakami T; Sanemasa M; Nasu R; Nagai J; Takano M
    Drug Metab Dispos; 2001 Feb; 29(2):145-51. PubMed ID: 11159804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of verapamil on the pharmacokinetics of oridonin in rats.
    Liu J; Zhang N; Li N; Fan X; Li Y
    Pharm Biol; 2019 Dec; 57(1):787-791. PubMed ID: 31747844
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of psoralen on the pharmacokinetics of anastrozole in rats.
    Zhang Y; Wu J; Zhou Y; Yin Y; Chen H
    Pharm Biol; 2018 Dec; 56(1):433-439. PubMed ID: 30345900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of permeability-limited physiologically-based pharmacokinetic models: part II - prediction of P-glycoprotein mediated drug-drug interactions with digoxin.
    Neuhoff S; Yeo KR; Barter Z; Jamei M; Turner DB; Rostami-Hodjegan A
    J Pharm Sci; 2013 Sep; 102(9):3161-73. PubMed ID: 23686764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlapping substrate specificities of cytochrome P450 3A and P-glycoprotein for a novel cysteine protease inhibitor.
    Zhang Y; Guo X; Lin ET; Benet LZ
    Drug Metab Dispos; 1998 Apr; 26(4):360-6. PubMed ID: 9531525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.